Smith Todd N Insider Trades

Insider Trading History

Track insider trading activity for Smith Todd N. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Assertio Holdings
Assertio Holdings ASRT
Director, Pres & CEO
Holding Value $15.2M 644,925 shares
Last Trade
May 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.8M 644,925 shares
$54.00
$23.50
Assertio Holdings
Assertio Holdings ASRT
Director, Pres & CEO
Holding Value $14.2M 603,750 shares
Last Trade
May 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.6M 603,750 shares
$54.00
$23.50
Assertio Holdings
Assertio Holdings ASRT
Director, Pres & CEO
Holding Value $10.6M 450,000 shares
Last Trade
May 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.3M 450,000 shares
$54.00
$23.50
IVERIC bio
IVERIC bio ISEE
SVP & CCO
Holding Value $220k 5,500 shares
Last Trade
Jan 02, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$251k 5,500 shares
$45.60
$39.95
IVERIC bio
IVERIC bio ISEE
SVP & CCO
Holding Value $55.9k 1,400 shares
Last Trade
Jan 02, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.8k 1,400 shares
$45.60
$39.95
IVERIC bio
IVERIC bio ISEE
SVP & CCO
Holding Value $5.99M 150,000 shares
Last Trade
Oct 03, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.76M 150,000 shares
$38.41
$39.95
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & Chief Commercial Officer
Holding Value $7.21M 62,000 shares
Last Trade
Sep 19, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$787k 62,000 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & Chief Commercial Officer
Holding Value $7.09M 61,000 shares
Last Trade
Sep 19, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$775k 61,000 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & Chief Commercial Officer
Holding Value $6.3M 54,138 shares
Last Trade
Sep 19, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$688k 54,138 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & Chief Commercial Officer
Holding Value $4.8M 41,250 shares
Last Trade
Sep 19, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$524k 41,250 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & Chief Commercial Officer
Holding Value $2.54M 21,880 shares
Last Trade
Sep 19, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$278k 21,880 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & Chief Commercial Officer
Holding Value $2.2M 18,955 shares
Last Trade
Sep 19, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$241k 18,955 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & Chief Commercial Officer
Holding Value $779k 6,699 shares
Last Trade
Sep 19, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.1k 6,699 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Sep 19, 2014 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$775k 61,000 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Sep 19, 2014 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$278k 21,880 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Sep 19, 2014 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$688k 54,138 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Sep 19, 2014 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$787k 62,000 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Sep 19, 2014 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$241k 18,955 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
Evp, Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Sep 19, 2014 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$889k 70,000 shares
$12.70
$116.30
Horizon Therapeutics Plc
Horizon Therapeutics Plc HZNP
EVP & Chief Commercial Officer
Holding Value $8.14M 70,000 shares
Last Trade
Sep 19, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$889k 70,000 shares
$12.70
$116.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up